$101 Million is the total value of Velan Capital Investment Management LP's 24 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FEZ | New | SPDR INDEX SHS FDSput | $15,380,000 | – | 500,000 | +100.0% | 15.26% | – |
ZYME | New | ZYMEWORKS INC | $1,445,000 | – | 234,902 | +100.0% | 1.43% | – |
BLU | New | BELLUS HEALTH INC NEW | $1,056,000 | – | 100,000 | +100.0% | 1.05% | – |
COLL | New | COLLEGIUM PHARMACEUTICAL INC | $640,000 | – | 39,957 | +100.0% | 0.64% | – |
New | LUMIRADX LTD | $583,000 | – | 571,428 | +100.0% | 0.58% | – | |
ASRT | New | ASSERTIO HOLDINGS INC | $533,000 | – | 234,766 | +100.0% | 0.53% | – |
GKOS | New | GLAUKOS CORP | $367,000 | – | 6,896 | +100.0% | 0.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
TELA BIO INC | 8 | Q3 2023 | 7.6% |
REZOLUTE INC | 8 | Q3 2023 | 1.3% |
OPTINOSE INC | 7 | Q3 2023 | 7.9% |
IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-03-28 |
13F-HR | 2024-02-14 |
4 | 2024-02-09 |
SC 13D/A | 2024-02-09 |
SC 13G/A | 2024-01-29 |
13F-HR | 2023-11-13 |
4 | 2023-10-04 |
4 | 2023-08-17 |
SC 13D/A | 2023-08-16 |
13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.